Detalles de la búsqueda
1.
Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes.
Haematologica
; 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572567
2.
Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study.
Haematologica
; 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38186346
3.
Retinoic acid-responsive CD8 effector T cells are selectively increased in IL-23-rich tissue in gastrointestinal GVHD.
Blood
; 137(5): 702-717, 2021 02 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32905596
4.
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience.
Br J Haematol
; 198(3): 492-502, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35485402
5.
Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia.
Br J Haematol
; 180(3): 346-355, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29076145
6.
TNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses.
Blood
; 128(1): 72-81, 2016 07 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27103745
7.
Inhibition of phosphatidylinositol-3-kinase by the furanosesquiterpenoid hibiscone C.
Bioorg Med Chem Lett
; 27(14): 3087-3091, 2017 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28551103
8.
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis.
Hemasphere
; 8(6): e87, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38873532
9.
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme.
Blood Cancer J
; 14(1): 66, 2024 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38622139
10.
Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.
Hemasphere
; 8(5): e62, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38774657
11.
Effective bridging therapy can improve CD19 CAR-T outcomes while maintaining safety in patients with large B-cell lymphoma.
Blood Adv
; 7(12): 2872-2883, 2023 06 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36724512
12.
Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.
J Immunother Cancer
; 11(4)2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37072350
13.
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
Front Immunol
; 14: 1252811, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37828980
14.
Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease working party study from the European Society for Blood and Marrow Transplantation registry.
Front Immunol
; 14: 1125824, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36960069
15.
Detection of CAR-T19 cells in peripheral blood and cerebrospinal fluid: An assay applicable to routine diagnostic laboratories.
Cytometry B Clin Cytom
; 100(6): 622-631, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33915021
16.
Improved COVID-19 outcomes in CAR-T patients in the age of vaccination and preemptive pharmacotherapeutics.
Leuk Lymphoma
; 64(12): 2037-2041, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37602678
17.
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia - real-world resource use data.
Leuk Lymphoma
; 61(2): 491-493, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31580171
Resultados
1 -
17
de 17
1
Próxima >
>>